Fierce Pharma

With the FDA's Moderna decision, vaccine makers face increasingly uncertain regulatory environment

Mani Foroohar, M.D., of Leerink Partners, says that the decision reflects “how sharp the departure has been between the prior ...
STAT

FDA’s rejection of Moderna threatens to stifle broader vaccine industry

Experts say the FDA "moved the goalposts" on Moderna, creating "a destructive precedent that will undermine the future of vaccine development" in the U.S.
Medscape

Vaccine Trials Advance Pneumovirus Prevention

From early failures to prefusion F protein breakthroughs, RSV vaccine development has accelerated, reshaping prevention ...

HIV antibody opens up new approaches for vaccine development and combination therapies

An international research team has identified a novel HIV antibody that targets the virus at a particularly vulnerable site and overcomes previous limitations of known antibodies. This study, led by ...

Vaccine innovation vs. the bureaucracy

Regulators move the goalposts for a manufacturer that uses mRNA technology.

Vaccines are a national security issue, says global health official

LONDON, Feb 13 (Reuters) - Vaccines are a matter of national security, a leading global health figure said this week, warning that rising anti-vaccine sentiment worldwide could undermine efforts to ...